Introduction
Mesenchymal stem cells, also known as multipotent stromal cells (MSCs), and skeletal stem cells are non-hematopoietic stem/progenitor cells originally isolated from the bone marrow (BM) (1) . They are characterized in vitro by their fibroblast-like morphology, adherence to plastic surface and extensive proliferative ability in an uncommitted state while retaining the potential to differentiate along various lineages of mesenchymal origin, including adipocyte, osteoblast, chondrocyte and adventitial reticular cell (BM stroma) lineages, in response to appropriate stimuli (2, 3) . It has been recently shown that in addition to the BM, MSCs or 'MSClike' cells with similar features reside in virtually all murine (4) and human (5, 6) organs.
MSCs cultured in vitro express a number of cell surface markers, which serve to identify MSCs; however, none of these markers is solely specific to MSCs. There is a consensus that human MSCs are uniformly positive for CD44, CD73, CD90 and CD105 (7) . However, murine MSCs express stem cell antigen-1 (Sca-1) and CD44, but they vary in the frequency of the CD73-, CD90-and CD105-positive cells (8) (9) (10) . Murine MSCs of different tissue origin have primarily been characterized regarding their phenotype and in some studies by their capacity to differentiate into mesodermal cell types (11, 12) . However, one of the most prominent MSC function, the in vitro and in vivo immunosuppressive activity, has been analyzed solely in BM and adipose tissue but not in stromal cells isolated from other organs (13, 14) . This immunosuppressive activity has recently been handled with special interest due to its usefulness in cell-based therapies (15) (16) (17) .
Several studies have demonstrated that MSCs can serve as precursors to cartilage and bone regeneration after direct in vivo injection into injured animals (18) . Moreover, a beneficial therapeutic role for MSCs that does not relate to direct tissue replacement has been noted in models of heart, lung, kidney and nervous system injury, as well as in the treatment of some autoimmune and inflammatory diseases (19) . In these studies, it has been proposed that the beneficial effects of MSCs merely rely on their ability to down-regulate immune responses and to secrete various key trophic factors, which can exert a tremendous effect on tissue repair through modulating local environment and activation of endogenous stem cells. The trophic activity inhibits ischemia-induced apoptosis and scarring while stimulating angiogenesis and the proliferation of intrinsic tissue stem and progenitor cells (20) .
Since very limited number of works have explored the possible functional role of MSCs derived from lymphoid organs or vascular wall, we compared the immunophenotype, differentiation ability to adipocyte and bone and immunomodulatory activity of MSCs isolated from different organs, such as BM, spleen (Spl), thymus (Th) and aorta wall (Ao) of juvenile (14 days old) C57Bl/6 mice. We have chosen animals of this young age to obtain MSCs since in older mice most of the tissue stem cells become dormant (2, 19) .
Methods

Animals
Juvenile (14 days of age) C57Bl/6 and adult (10-12 weeks of age) C57Bl/6 and Balb/c (National Institute of Oncology, Budapest, Hungary) mice were used for all experiments under the guidelines of the Animal Care and Use Committee of the National Blood Service (Budapest, Hungary).
Isolation and culture of MSCs
Murine MSCs were isolated and expanded using a modified method of Peister et al. (11) . Briefly, juvenile C57Bl/6 mice were sacrificed by cervical dislocation and the femurs, thymus, spleen and aorta were removed. BM cells were collected by flushing femurs and tibias with complete medium (CM) containing DMEM/Ham's F-12 medium (Invitrogen, Carlsbad, CA, USA), 10% fetal bovine serum, 5% horse serum (Invitrogen), 50 U ml À1 penicillin, 50 lg ml À1 streptomycin (Sigma-Aldrich, St Louis, MO, USA) and 2 mM L-glutamine (Invitrogen) and supplemented with heparin at a final concentration of 5 U ml
À1
. Cells from the thymus, spleen and aorta were obtained by mechanical disruption as follows: the dissected organs were washed with PBS, transferred into CM, cut into smaller fragments and subsequently minced with needles. The samples were then washed and filtered through a 60-lm nylon mesh filter to remove debris. Cells were then washed twice in Hanks' balanced salt solution, plated in a 25-cm 2 flask (BD Falcon, Bedford, MA, USA) at a density of 2-4 3 10 6 cells cm À2 in CM and cultured in a humidified 5% CO 2 incubator at 37°C for 72 h. Non-adherent cells were removed by sequential changes of the medium twice a week. Confluent primary cultures were washed with PBS and lifted by incubation with trypsin-EDTA at 37°C for 5 min. Cells were then washed again, diluted at a ratio 1:5 and seeded into a 75-cm 2 flask (BD Falcon). Subsequent passages were performed similarly.
Since cultures are morphologically heterogeneous and contain hematopoietic cells of BM origin until passage 6 or 7, therefore adherent cells were used between passages 10 and 25 in all experiments.
Characterization of MSCs
For detection of surface antigens, MSCs were retrieved by trypsin digestion, and aliquots of 5 3 10 5 cells were labeled in the dark with FITC or PE-conjugated monoclonal antibodies against mouse Sca-1, CD34, CD44, CD73, CD90.2 and CD105 or with biotin-conjugated anti-CD3e, CD45R/B220, CD11b, Ly-6G, TER-119 and CD119 (all products from BD Pharmingen, San Diego, CA, USA) for 30 min at 4°C. Biotinylated antibodies were incubated with PE-conjugated streptavidin (Sigma-Aldrich).
Cell surface expression of MHC II molecules was also determined by flow cytometry. MSCs isolated from different organs were incubated in the presence or absence of IFN-c (100 ng ml To evaluate intracellular alpha smooth muscle actin (a-SMA) expression, MSCs derived from different sources were seeded onto chambered slides (BD Falcon), fixed with PFA and labeled with a Cy3-conjugated monoclonal antia-SMA antibody (Sigma-Aldrich). Images were obtained with Olympus BX512 epifluorescent microscope (Olympus, Tokyo, Japan) and Fview II digital camera (Olympus).
Evaluation of adipogenic and osteogenic differentiation was performed by using the previously described method of Pittenger et al. (21) . Adipogenic medium consisted of DMEM supplemented with 10% FCS, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX; Sigma-Aldrich) and 10 À7 M dexamethasone (Sigma-Aldrich). Osteogenic medium was composed of DMEM supplemented with 10% FCS, 10 mM b-glycerophosphate (Sigma-Aldrich), 50 lg ml À1 ascorbic acid (Sigma) and 0.1 lM hydrocortisone (Sigma-Aldrich). MSCs were cultured in the specific differentiation media for 14 days and then fixed and stained with Alizarin Red S (Sigma-Aldrich) (for calcium deposition) or with Oil Red O (Sigma-Aldrich) (for lipid droplets). Photomicrographs were taken with an inverted microscope (Olympus CK2) and a digital camera (Nikon Coolpix 4500, Tokyo, Japan).
Progenitor (colony-forming cell) assays
To determine whether the isolated MSC cultures contain any residual colony-forming unit granulocyte-macrophage, burst-forming unit erythroid and colony-forming unit-mix, the Methocult GF M3434 semi-solid colony-forming cell assay (Stem Cell Technologies, Vancouver, Canada) was used, following the manufacturer's instructions.
T-cell proliferation
MSCs were seeded in 100 ll cultures in 96-well flat-bottom plates (BD Falcon) in CM at the indicated cell density and cultured for 24 h at 37°C. 
Diabetes model
Streptozotocin (STZ)-induced type 1 diabetes model was performed as previously described (22) . Briefly, 8-to 10-weekold female C57Bl/6 mice injected with multiple low doses (50 mg kg À1 intra-peritoneally) of STZ (Sigma-Aldrich). Syngeneic (male C57Bl/6), freshly prepared whole BM-nucleated cells (10 6 cells per animal) and culture-expanded MSCs (10 5 cells per animal) were delivered intravenously into minimally injured (250 cGy whole-body irradiation) diabetic mice at day 15 after STZ administration. Blood glucose level and glucose tolerance were measured as previously described (22) .
Statistical analysis
Data were expressed as mean 6 SD. Comparisons of parameters among the groups were made by the Student's t-test or non-parametric Mann-Whitney test. Differences were considered significant at P < 0.05.
Results
Isolation and characterization of BM-, thymus-, spleen-and aorta-derived MSCs
We isolated and propagated plastic adherent stromal cells from the BM, Th, Spl and Ao of 14-day-old C57Bl/6 mice. Our initial experiments carried out here indicated that the cultures usually remained morphologically and immunophenotypically heterogeneous until passage 6 or 7 (data not shown); therefore, adherent cells between passages 10 and 25 were used in all subsequent experiments. Replicative senescence was never observed in any murine MSC cultures (data not shown). From passage 10 onwards, all stromal cell population was positive for expression of Sca-1 and CD44, although in different extent; Ao-MSC were only slightly positive for Sca-1 and Th-MSC for CD44. CD73 was expressed by BM-, and Ao-MSC, and CD105 was present on and BM-, Spland Ao-MSC. There was no significant amount of CD90.2 detected on any of the MSC cultures (Fig. 1A) . It is of note that CD90.2-positive cells were found during the earlier passages of stromal cells or, later on, at a very high cell density. Similar tendency was observed in terms of CD73 expression during the long culture period. In contrast, Sca-1 expression showed an opposite tendency, i.e. to increase with higher number of passages in culture (data not shown). None of the MSCs expressed hematopoietic markers such as CD34, CD3e, CD45R/B220, CD11b, Ly-6G or Ter-119 (Fig. 1B and data not shown). The cultured stromal cells did not form granulocyte-macrophage, erythroid-or mixed-hematopoietic colonies in semi-solid media (data not shown), confirming that the cultures were free from hematopoietic contaminants.
Flow cytometry analysis also demonstrated that MSCs are negative for surface MHC II antigens, whereas IFN-c upregulated surface expression of MHC II molecules on BM-, Spl-and Ao-MSCs, but not on Th-MSCs ( Fig. 2A) , nonetheless the thymus-derived cells were also positive for IFN-c receptor (CD119) (Fig. 2B) .
Moreover, the cultures of various tissue of origin showed morphological homogeneity and similarity after 10 passages ( Fig. 3A) . A vascular smooth muscle-specific protein, a-SMA, was expressed in 40-60% of BM-, Th-and Spl-MSCs, whereas aorta-derived MSCs were uniformly (100%) positive for this marker (Fig. 3B ).
To verify that the stromal cell cultures contained multipotent MSCs, the cells were cultured under various conditions to assess their capacity to differentiate into committed mesodermal lineages. Culturing the cells in adipogenic or osteogenic media, MSCs acquired intracellular lipid droplets (Fig. 3C) or deposited a calcium-rich mineralized matrix (Fig. 3D) , respectively, demonstrating the multipotency of these cells. Differentiation capabilities of MSCs from different sources varied as MSCs from BM, thymus and spleen differentiated readily, whereas aorta-derived MSCs differentiated weakly into adipocytes. In contrast, thymus-derived MSCs produced little mineralized matrix compared with BM-, spleen-and aorta-derived MSCs. Spontaneous adipogenic differentiation was also observed in high-density MSC cultures of BM or spleen (data not shown). The results described in this section have been summarized in Table 1 .
Effect of MSCs on mitogen-or alloantigen-induced T-cell proliferation
Next, we analyzed immunoregulatory activity of adherent stromal cells of different tissue origin. As shown in Fig. 4(A) , BMand Spl-MSCs had a similar dose-dependent inhibitory effect on ConA-stimulated T-cell proliferation. Maximal (65-75%) 556 Immunosuppressive activity of different mouse MSCs inhibition of 3 H-thymidine incorporation was detected at 1:10 to 1:40 T-cell to MSC ratio. Aorta-and thymus-derived MSCs had medium and very low inhibitory activity, respectively. Spontaneous T-cell proliferation was not inhibited by any of the MSC populations used in these experiments (data not shown).
Similar results were obtained when MLR was performed as BM-and Spl-MSCs had the highest, Ao-MSCs had medium and Th-MSCs had the lowest inhibitory effect on allogeneic stimulation of T-cells (Fig. 4B) .
In vivo therapeutical effect of MSCs of different tissue origin in STZ-induced diabetes
As we have recently described (22) , co-injection of syngeneic nucleated BM cells and in vitro expanded syngeneic or allogeneic BM-MSCs into sub-lethally irradiated (250 cGy) diabetic mice efficiently reversed the disease. Furthermore, we have also shown that the recovery was not a result of differentiation of grafted cells into insulin-producing b-cells but rather a consequence of an endogenous repair process initiated by the graft and suppression of T-cell-mediated immune response against newly formed b-cells by the donor MSCs. Whether MSCs from different sources could contribute equally to diabetes therapy, BM-, Spl-, Ao-and Th-MSCs were used in murine STZ-induced diabetes model. Survival curves showed that therapeutical efficiency of BM-, Spl-and AoMSCs, but not that of Th-MSCs, was comparable (Fig. 5A) . Recovering from hyperglycemia measured by blood glucose concentration (Fig. 6) , and intra-peritoneal glucose tolerance test (Fig. 5B ) occurred after 12 weeks of transplantating BM-, Spl-and Ao-MSCs but not Th-MSCs. Moreover, MSCs from any source did not affect the disease progression when administered alone (data not shown).
Discussion
There are a growing number of reports of putative MSCs or MSC-like cells isolated from various mouse (4) and human (5, 6) tissues and organs. Although there is an intensive debate about how MSCs can be distinguished from tissue fibroblasts, myofibroblast or perivascular cells, it is accepted that the former adherent cells carry some or all 'MSC-specific' cell surface molecules and are able to differentiate into adipocytes, chondrocytes and bone (2, 3, 23) . To determine whether MSCs or MSC-like cells isolated from different murine tissues are phenotypically and functionally similar to each other, BM, spleen, aorta wall and thymus adherent cells were isolated and their long-term cultures were established from 14-day-old C57Bl/6 mice. Animals of this young age were chosen to obtain MSCs before the end of the puberty (4 weeks of age in mice), when most of the tissue stem cells became dormant. Although MSCs isolated from all juvenile sources fulfilled the requirements for definition of MSCs and had similar morphology, there were many differences observed regarding the cell surface marker pattern and the extent of ability to differentiate into other cell lineages (Table 1) . Notably, accordingly to previous findings (8-12), we found uniform phenotypic changes within the heterogeneous population of the MSCs following successive passages. For example, CD90.2 was detected in early culture of MSCs then remained absent after 10 passages. In addition, consistently with earlier reports (24, 25) , MHC II molecules were expressed on BM-, Spl-and Ao-MSCs after stimulation with high amount of IFN-c. More importantly, first in the literature, we found that MSCs from various tissues exhibited marked difference in their immunosuppressive ability. T-cell anti-proliferative effects of BM-and Spl-MSCs were comparable, whereas of Ao-and Th-MSCs were weaker but significant and negligible, respectively, in mitogen-or alloantigen-driven T-cell proliferation assays (Fig. 4) . The in vitro data were validated in vivo in a murine STZ-induced experimental diabetes model. We have previously characterized the in vivo effect of MSCs isolated from the BM of adult C57Bl/6 and Balb/c mice in the above model (22) . Juvenile BM-, Spl-and Ao-MSCs contributed efficiently to cellular treatment of diabetes, while Th-MSCs were unable to co-operate with freshly prepared whole BM cells (Figs 5 and 6 ). The marked difference in the immunoregulatory activity of the thymus-derived MSCs and those prepared from other tissues could be interpreted at least on two, not mutually exclusive ways. First, MSCs migrating into the special tissue microenvironments of the thymus may adapt to this specific niche, where T-cell development occurs and immunosuppressive activity of MSCs would not be beneficial since it could block the selection program of the immature T cells. The second possibility is that the thymic mesenchymal compartment, unlikely that of other tissues, can derive from the neural crest rather than the mesoderm, as already suggested by others (26, 27) . However, because Krampera et al. (28) isolated MSCs with immunosuppressive activity from adult human thymus, further studies have to be completed to clarify this controversy. In fact, it could be a species difference.
Based on the above findings, in addition to providing some new insight into MSC biology, it can be speculated that MSCs obtained and expanded in culture from the most, but not all tissues or organs, could be used for therapeutic purposes. In further studies, it should be determined whether MSCs of various tissue origins derive from the same parent cell type migrating into the different organs and hence ensuring the renewal of the stroma at a specific site. This conceivable hypothesis is supported by the differentiation of specific tissue macrophages engaging their final phenotype and function in their target tissue environment.
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